MARA Holdings
MARA
MicroStrategy
MSTR
Coinbase
COIN
NVIDIA
NVDA
Tesla
TSLA
US Stock MarketDetailed Quotes
VIGL Vigil Neuroscience
- 1.930
- +0.040+2.12%
Close Jan 17 16:00 ET
- 1.930
- 0.0000.00%
Post 20:01 ET
78.90MMarket Cap-0.93P/E (TTM)
1.950High1.865Low51.01KVolume1.930Open1.890Pre Close97.29KTurnover0.23%Turnover RatioLossP/E (Static)40.88MShares6.06052wk High0.89P/B42.81MFloat Cap1.49052wk Low--Dividend TTM22.18MShs Float18.270Historical High--Div YieldTTM4.50%Amplitude1.490Historical Low1.907Avg Price1Lot Size
About Vigil Neuroscience Company
Vigil Neuroscience, Inc. engages in the provision of biotechnology research services. Its focus is improving the lives of patients, caregivers, and families affected by neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. The company was founded on June 22, 2020 and is headquartered in Watertown, MA.
Company Profile
SymbolVIGL
Company NameVigil Neuroscience
Listing DateJan 7, 2022
Issue Price14.00
Founded2020
CEODr. Ivana Magovcevic-Liebisch, J.D.,PhD
MarketNASDAQ
Employees69
Fiscal Year Ends12-31
Address100 Forge Road,Suite 700
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-857-254-4445
Websitehttp://www.vigilneuro.com
Company Executives
- Name
- Position
- Salary
- Dr. Ivana Magovcevic-Liebisch, J.D.,PhD
- President, Chief Executive Officer and Director
- 3.85M
- David L.F. Gray, PhD
- Chief Science Officer
- 2.77M
- Petra Kaufmann, F.A.A.N.,M.D.
- Chief Medical Officer
- --
- Jennifer Ziolkowski, C.P.A.
- Chief Financial Officer and Principal Accounting Officer
- 1.70M
- Dr. Bruce Booth, D.Phil.
- Chairman of the Board
- 165.00K
- Mary T. Thistle
- Independent Director
- 143.83K
- Dr. Suzanne L. Bruhn, PhD
- Independent Director
- 138.50K
- Dr. Cheryl Renee Blanchard, M.S.,PhD
- Independent Director
- 140.00K
- Stefan Vitorovic, M.B.A.,M.S.
- Independent Director
- 136.83K
- Dr. Samantha L. Budd Haeberlein, PhD
- Independent Director
- 311.35K
- Dr. Gerhard Koenig, PhD
- Independent Director
- 136.33K
- Christopher Verni, J.D.
- General Counsel and Corporate Secretary
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.